197 related articles for article (PubMed ID: 16835228)
1. Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma.
Winn RA; Van Scoyk M; Hammond M; Rodriguez K; Crossno JT; Heasley LE; Nemenoff RA
J Biol Chem; 2006 Sep; 281(37):26943-50. PubMed ID: 16835228
[TBL] [Abstract][Full Text] [Related]
2. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.
Winn RA; Marek L; Han SY; Rodriguez K; Rodriguez N; Hammond M; Van Scoyk M; Acosta H; Mirus J; Barry N; Bren-Mattison Y; Van Raay TJ; Nemenoff RA; Heasley LE
J Biol Chem; 2005 May; 280(20):19625-34. PubMed ID: 15705594
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1.
Tennis MA; Van Scoyk M; Heasley LE; Vandervest K; Weiser-Evans M; Freeman S; Keith RL; Simpson P; Nemenoff RA; Winn RA
Neoplasia; 2010 Mar; 12(3):244-53. PubMed ID: 20234818
[TBL] [Abstract][Full Text] [Related]
4. Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.
Tennis MA; Van Scoyk MM; Freeman SV; Vandervest KM; Nemenoff RA; Winn RA
Mol Cancer Res; 2010 Jun; 8(6):833-43. PubMed ID: 20501643
[TBL] [Abstract][Full Text] [Related]
5. Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB.
Bren-Mattison Y; Meyer AM; Van Putten V; Li H; Kuhn K; Stearman R; Weiser-Evans M; Winn RA; Heasley LE; Nemenoff RA
Mol Pharmacol; 2008 Mar; 73(3):709-17. PubMed ID: 18055759
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail.
Choudhary R; Li H; Winn RA; Sorenson AL; Weiser-Evans MC; Nemenoff RA
Neoplasia; 2010 Mar; 12(3):224-34. PubMed ID: 20234816
[TBL] [Abstract][Full Text] [Related]
7. Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancer.
Avasarala S; Bikkavilli RK; Van Scoyk M; Zhang W; Lapite A; Hostetter L; Byers JT; Heasley LE; Sohn JW; Winn RA
PLoS One; 2013; 8(10):e76895. PubMed ID: 24204697
[TBL] [Abstract][Full Text] [Related]
8. Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility.
Rapp J; Kiss E; Meggyes M; Szabo-Meleg E; Feller D; Smuk G; Laszlo T; Sarosi V; Molnar TF; Kvell K; Pongracz JE
BMC Cancer; 2016 Nov; 16(1):915. PubMed ID: 27876017
[TBL] [Abstract][Full Text] [Related]
9. The Frizzled family of unconventional G-protein-coupled receptors.
Schulte G; Bryja V
Trends Pharmacol Sci; 2007 Oct; 28(10):518-25. PubMed ID: 17884187
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cells.
Han S; Rivera HN; Roman J
Am J Respir Cell Mol Biol; 2005 Apr; 32(4):350-9. PubMed ID: 15677767
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
Han EJ; Im CN; Park SH; Moon EY; Hong SH
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e239-48. PubMed ID: 23332223
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling pathway in non-small cell lung cancer.
Stewart DJ
J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone inhibits alpha4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor gamma-independent signals.
Sun X; Ritzenthaler JD; Zheng Y; Roman J; Han S
Mol Cancer Ther; 2009 Jan; 8(1):110-8. PubMed ID: 19139119
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Frizzled 6 membrane mobility by FRAP supports G protein coupling and reveals WNT-Frizzled selectivity.
Kilander MB; Dahlström J; Schulte G
Cell Signal; 2014 Sep; 26(9):1943-9. PubMed ID: 24873871
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.
Han S; Roman J
Mol Cancer Ther; 2006 Feb; 5(2):430-7. PubMed ID: 16505118
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).
Bren-Mattison Y; Van Putten V; Chan D; Winn R; Geraci MW; Nemenoff RA
Oncogene; 2005 Feb; 24(8):1412-22. PubMed ID: 15608671
[TBL] [Abstract][Full Text] [Related]
17. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
Tang Q; Wu J; Zheng F; Hann SS; Chen Y
Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826
[TBL] [Abstract][Full Text] [Related]
18. AP-1 transcription factor complex is a target of signals from both WnT-7a and N-cadherin-dependent cell-cell adhesion complex during the regulation of limb mesenchymal chondrogenesis.
Tufan AC; Daumer KM; DeLise AM; Tuan RS
Exp Cell Res; 2002 Feb; 273(2):197-203. PubMed ID: 11822875
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor γ (PPARγ) plays a critical role in the development of TGFβ resistance of H460 cell.
Lin LC; Hsu SL; Wu CL; Liu WC; Hsueh CM
Cell Signal; 2011 Oct; 23(10):1640-50. PubMed ID: 21664967
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
Wang M; Li G; Yang Z; Wang L; Zhang L; Wang T; Zhang Y; Zhang S; Han Y; Jia L
Oncotarget; 2017 Jan; 8(5):8083-8094. PubMed ID: 28042952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
